References
- Soller RW. Prescription-to-Over-the-Counter Switch Criteria. Drug Inf J 2002;36:309-17
- Part IV of Regulation EC726/2004 on the European Medicines Agency. http://www.emea.europa.eu
- Directive 2001/83/EC of the European parliament and of the council of 6 November 2001 on the Community code relating to medicinal products for human use. Off J Eur Commun 2001;L 311. http://eur-lex.europa.eu/LexUriServ/LexUriServ.do?uri=OJ:L:2001:311:0067:0128:en:PDF. Accessed June 21, 2011
- Association of the European Self-Medication Industry. The Table of OTC Ingredients in 14 EU countries. http://www.wsmi.org/otc.htm
- Mahecha LA. Rx-to-OTC switches: trends and factors underlying success. Nat Rev Drug Discov 2006;5:380-5
- Hemwall EL. Increasing access to nonprescription medicines: a global public health challenge and opportunity. Clin Pharmacol Ther 2010;87:267-9
- SWITCH Prescription to nonprescription medicines switch. WSMI 2009. http://www.wsmi.org/pdf/wsmi_switchbrochure.pdf
- Datamonitor. Pharmaceutical Key Trends 2011- Generics Market Overview: patent cliff set to drive global generic uptake despite tougher market conditions. 2011. http://www.researchandmarkets.com/reports/1772721/pharmaceutical_key_trends_2011_generics_market Publisher = Datamonitor? Location=? Year = April2011
- Soller W. Prescription-to-over-the-counter switch criteria. Drug Info J 2002;36:309-17
- Cohen J, DiMasi J. Modeling a switch of loratadine from prescription to over-the-counter status. J Res Pharmaceut Econ 2001;11:43-54
- Sullivan PW, Follin SL, Nichol MB. Transitioning the second-generation antihistamines to over-the-counter status: a cost-effectiveness analysis. Med Care 2003;41:1382-95
- Sullivan PW, Nichol MB. The economic impact of payer policies after the Rx-to-OTC switch of second-generation antihistamines. Value Health 2004;7:402-12
- Amirsadri-Naeini M, Jackson PR. Comparison of cost-effectiveness of POM (prescription only) statins; OTC (over the counter) statin and plant sterol/stanol products for primary CVD (cardiovascular disease) prevention in the UK from the patient's perspective. ISPOR 13th Annual International Meeting Toronto, Ontario, Canada May, 2008
- Gandhi P, McGhan W, Peterson A. Cost-utility analysis using a Markov model to compare prescription statins versus potential over the counter statins in USA. ISPOR 9th Annual European Congress, Copenhagen, Denmark, October, 2006
- Gandhi P, McGhan W, Peterson A. Decision analysis to compare the cost-effectiveness of the statins available by prescription versus over the counter based from a societal perspective. ISPOR 11th Annual International Meeting, Philadelphia, PA, May, 2006
- Kalish SC, Bohn RL, Avorn J. Policy analysis of the conversion of histamine2 antagonists to over-the-counter use. Med Care 1997;35:32-48
- Kunz K, Arundell E, Cisternas M, et al. Economic implications of selftreatment of heartburn/nonulcer dyspepsia with nonprescription famotidine in a managed care setting. J Managed Care Pharm 1996;2:263-271
- Zhu M, Wertheimer AI, Field R. The financial impact of over-the-counter availability of oral contraceptive pills. J Res Pharm Econ 2002;11:125-42 . http://works.bepress.com/robert_field/12/
- Keeler TE, Hu TW, Keith A, et al. The benefits of switching smoking cessation drugs to over-the-counter status. Health Econ 2002;11:389-402
- Chang JY, Nichol MB. The economic impact of transitioning valacyclovir to over the counter status for the treatment of genital herpes. ISPOR 14th Annual International Meeting Orlando, FL, USA May, 2009
- Association Européenne des Spécialités Pharmaceutiques Grand Public. The economic and public health value of self-medication. 2011. http://www.aesgp.eu/media/cms_page_media/68/2004study.pdf
- Shih YC, Prasad M, Luce BR, et al. The effect on social welfare of a switch of second-generation antihistamines from prescription to over-the-counter status: a microeconomic analysis. Clin Therapeut 2002;24:701-16
- Alexander GC, Mohajir N, Meltzer DO. Consumers' perceptions about risk of and access to nonprescription medications. J Am Pharm Assoc 2005;45:363-70 . http://www.abimip.org.br/uploads/material_de_apoio/1296056417_792.pdf
- Roper Starch Worldwide. Self-care in the new millennium – American attitudes toward maintaining personal health and treatment. Washington, 2001. http://www.abimip.org.br/uploads/material_de_apoio/1296056417_792.pdf
- Lipsky MS, Waters T. The “prescription-to-OTC switch” movement. Its effects on antifungal vaginitis preparations. Arch Fam Med 1999;8:297-300